The IL-10 inhibitory peptide exerted an anticancer effect on lymphoma B cells and was able to eliminate the inhibitory effect of 1L-10 on macrophages; the computer-designed NK20a has improved IL-10 receptor binding affinity and can serve as a tool for developing anticancer strategies [85]. Here, IL10 is linked to lymphoma.